297 related articles for article (PubMed ID: 2753273)
1. [Arrhythmogenic implications of non-iatrogenic thyroid dysfunction].
Inama G; Furlanello F; Fiorentini F; Braito G; Vergara G; Casana P
G Ital Cardiol; 1989 Apr; 19(4):303-10. PubMed ID: 2753273
[TBL] [Abstract][Full Text] [Related]
2. Supraventricular arrhythmias and the relation to thyroid dysfunction in a group of Syrian patients.
Hadidy S; Issa F; Hourani N
Trop Geogr Med; 1986 Jun; 38(2):158-61. PubMed ID: 2426847
[TBL] [Abstract][Full Text] [Related]
3. [Pre and Postoperative evaluation of the incidence of arrhythmia in patients undergoing corrective intervention for Ebstein anomaly].
Brancaccio G; Chauvaud S; Carpentier A
Ital Heart J Suppl; 2000 Sep; 1(9):1173-9. PubMed ID: 11140286
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131].
Hermida JS; Jarry G; Tcheng E; Moullart V; Arlot S; Rey JL; Schvartz C
Arch Mal Coeur Vaiss; 2004 Mar; 97(3):207-13. PubMed ID: 15106744
[TBL] [Abstract][Full Text] [Related]
5. [Cardiac symptoms in endocrinologic disorders. Heart illness caused by the thyroid gland].
Stiefelhagen P
MMW Fortschr Med; 2009 May; 151(19):12-3. PubMed ID: 19827435
[No Abstract] [Full Text] [Related]
6. [Immune status of patients with cardiac arrhythmias: idiopathic and in primary heart disease].
Bekbosynova MS; Pichugin AV; Novikova DS; Gabrusenko SA; Kozhemiakina ESh; Ataullakhanova DM; Golitsyn SP; Ataullakhanov RI
Ter Arkh; 2006; 78(9):52-60. PubMed ID: 17076226
[TBL] [Abstract][Full Text] [Related]
7. [Effects of diltiazem in supraventricular paroxysmal tachyarrhythmias].
De Rosa F; Feraco E; Venneri N; Boncompagni F; Curia F; Guzzo D; Plastina F
G Ital Cardiol; 1986 Sep; 16(9):776-81. PubMed ID: 3803800
[TBL] [Abstract][Full Text] [Related]
8. [Experience with intravenous amiodarone in hyperkinetic supraventricular arrhythmias].
Ricevuti A; Bianchi C; Bonifazi C; Coppetti S; Ferrari O; Rinaldo R; Rizzi M; Tavecchi L; Zampaglione G; Ziletti G; Distante S
G Ital Cardiol; 1981; 11(6):812-9. PubMed ID: 7319187
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of hyperkinetic cardiac arrhythmia in chronic obstructive bronchopneumopathy].
Conte G; Lauro S; Lazzarin M; Rigon N; Perrone A
Minerva Cardioangiol; 1997 Sep; 45(9):429-33. PubMed ID: 9446064
[TBL] [Abstract][Full Text] [Related]
10. [The influence of subclinical thyroid dysfunction on cardiac hemodynamic and electrophysiological parameters in patients with coronary heart disease and paroxysmal atrial fibrillation].
Rakhmatullov FK; Klimova SV; Rudakova LE; Pchelinsteva SA; Rakhmatullov AF; Khodakova AI
Klin Med (Mosk); 2012; 90(10):31-4. PubMed ID: 23285759
[TBL] [Abstract][Full Text] [Related]
11. [Current diagnosis and treatment of cardiac arrhythmias of thyroid origin].
Gasiorowski W; Misztela G; Rusiecka-Kuczałek E; Kozioł-Otto G
Pol Tyg Lek; 1989 Feb 13-20; 44(7-8):188-90. PubMed ID: 2813177
[TBL] [Abstract][Full Text] [Related]
12. Paroxysmal ventricular tachycardia and paroxysmal atrial fibrillation associated with subclinical hyperthyroidism, chronic renal failure and elevation of prostate-specific antigen during acute myocardial infarction.
Patanè S; Marte F
Int J Cardiol; 2010 Feb; 138(3):e44-6. PubMed ID: 18722027
[TBL] [Abstract][Full Text] [Related]
13. [Arrhythmologic study of 50 patients with arrhythmogenic disease of the right ventricle: prognostic implications].
Bettini R; Furlanello F; Vergara G; Durante G; Bertoldi A; Visonà L; Dal Forno P; Camin G; Burelli C; Nicolosi GL
G Ital Cardiol; 1989 Jul; 19(7):567-79. PubMed ID: 2806788
[TBL] [Abstract][Full Text] [Related]
14. Impact of percutaneous transluminal septal myocardial ablation on refractory paroxysmal atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy.
Hosokawa Y; Takano H; Ohno T; Takayama M; Takano T
Angiology; 2008; 59(3):329-34. PubMed ID: 18388103
[TBL] [Abstract][Full Text] [Related]
15. [Incidence and timing of thyroid dysfunction with long-term amiodarone therapy].
Rouleau F; Baudusseau O; Dupuis JM; Victor J; Geslin P
Arch Mal Coeur Vaiss; 2001 Jan; 94(1):39-43. PubMed ID: 11233479
[TBL] [Abstract][Full Text] [Related]
16. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
[TBL] [Abstract][Full Text] [Related]
17. [Types and risk factors of arrhythmia on young patients with acute coronary syndrome in Henan province].
Zhao J; He F; Hu DY; Ding RJ; Yu XJ; Gou JJ; Wang L; Zhang P; Li XB; Guo JH; Liu WL; Li CL; Li L; Gao CY; Zhao LS; Chu YJ; Huang ZW; Wei JH; Hua SH; Liu RY; Zhuang XF
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jul; 41(7):572-6. PubMed ID: 24284184
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic specifics in atrial fibrillation in hyperthyroidism. Study of 14 cases].
Kamoun M; Haffani M; Basdeh L; Abid H; Kraiem S; Slimane H; Haddad A
Tunis Med; 2003 Dec; 81(12):932-6. PubMed ID: 14986528
[TBL] [Abstract][Full Text] [Related]
19. Treatment of arrhythmias during pregnancy.
Wolbrette D
Curr Womens Health Rep; 2003 Apr; 3(2):135-9. PubMed ID: 12628083
[TBL] [Abstract][Full Text] [Related]
20. [Arrhythmogenic effects of alcohol].
Krasniqi A; Bostaca I; Dima-Cosma C; Crişu D; Aursulesei V
Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1052-6. PubMed ID: 22276445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
